MedTrace Logo

PRESSUREwire Study

NCT02935088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2217

Last updated 2020-02-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.

Conditions

Interventions

DEVICE

Fractional Flow Reserve

Measurement of physiologic parameters

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Colin Berry, MD · University of Glasgow

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-12
Primary Completion
2019-03-22
Completion
2019-03-22

Countries

  • United States
  • Austria
  • Canada
  • Egypt
  • Estonia
  • Germany
  • Greece
  • India
  • Italy
  • Japan
  • Netherlands
  • Portugal
  • Saudi Arabia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935088 on ClinicalTrials.gov